What is the PRN.TO share price today?

This page shows the latest available Profound Medical Corp. (PRN.TO) price with its change against the prior close. Values are delayed or previous-close, not real-time.

Where is Profound Medical Corp. listed?

Profound Medical Corp. trades on the Toronto Stock Exchange under the symbol PRN.TO, ISIN CA74319B5027.

How large is Profound Medical Corp.?

Its market capitalisation is approximately 304.51M CAD, based on the latest available price and share count from our data provider.

Toronto Stock Exchange (TSX) · PRN.TO · ISIN CA74319B5027

Profound Medical Corp.

8.31 CAD

+0.08(+0.97%)

Previous close · Sep 18, 16:00 ET

Data last updated: Sep 18, 16:00 ET (20 h ago)· Delayed exchange data

Profound Medical Corp. (PRN.TO) trades on the Toronto Stock Exchange and operates in the Medical - Devices industry. Its market capitalisation is approximately 304.51M CAD. The company reports around 162 employees. Its ISIN is CA74319B5027. This page shows the latest available price, the day and 52-week ranges and an interactive chart. Quotes are delayed and are not intended for order execution.

Checking today's session…

Key facts

Exchange

Toronto Stock Exchange (TSX)

ISIN

CA74319B5027

Sector

Healthcare

Industry

Medical - Devices

Country

Market cap

301.97M CAD

Employees

162

Previous close

8.23 CAD

Day range

8.07 – 8.37

52-week range

5.93 – 12.40

Volume

11.06K

50-day average

9.63 CAD

200-day average

9.53 CAD

Asset type

Equity

About Profound Medical Corp.

Profound Medical Corp., along with its subsidiaries, operates as a commercial-stage medical technology firm. The company specializes in creating magnetic resonance (MR) guided ablation therapies designed to address prostate conditions, uterine fibroids, and to provide palliative pain management. Its market reach extends to Canada, Germany, the United States, and Finland. The company's primary offering is the TULSA-PRO system, which is engineered to integrate with magnetic resonance imaging (MRI) scanners within hospitals and clinical treatment facilities. Additionally, Profound Medical offers Sonalleve, a versatile therapeutic platform that treats uterine fibroids, delivers palliative pain relief for bone metastases, and provides non-invasive solutions for uterine fibroid treatment. Profound Medical Corp. maintains its corporate headquarters in Mississauga, Canada.

Company website

Frequently asked

What is the PRN.TO share price today?: This page shows the latest available Profound Medical Corp. (PRN.TO) price with its change against the prior close. Values are delayed or previous-close, not real-time.
Where is Profound Medical Corp. listed?: Profound Medical Corp. trades on the Toronto Stock Exchange under the symbol PRN.TO, ISIN CA74319B5027.
How large is Profound Medical Corp.?: Its market capitalisation is approximately 304.51M CAD, based on the latest available price and share count from our data provider.

All Profound Medical Corp. data comes from exchange and provider feeds for the Toronto Stock Exchange and is published for information, not as investment advice.

Real-time quotes are not licensed; prices are delayed or previous close, so they may lag the market by 15 minutes or a full session. Information only, not for trading. Where a figure is not covered by our licensed sources, the page says so rather than showing a substitute.